NCT06657248View on ClinicalTrials.gov

Clinical Performance and Safety of the Unicompartmental Univation® XF Pro Implant

Not yet recruitingOBSERVATIONAL
Enrollment

150

Participants

Timeline

Start Date

November 30, 2025

Primary Completion Date

February 28, 2026

Study Completion Date

February 28, 2031

Conditions
GonarthritisDegenerative Disease
Interventions
DEVICE

univation® XF Pro

Primary medial unicompartmental knee arthroplasty

Trial Locations (4)

14482

Oberlinklinik gGmbH, Potsdam

32257

Lukas Krankenhaus, Bünde

33034

St. Vincenz Hospital Brakel, Brakel

81377

LMU Großhadern, München

All Listed Sponsors
collaborator

Raylytic GmbH

INDUSTRY

lead

Aesculap AG

INDUSTRY

NCT06657248 - Clinical Performance and Safety of the Unicompartmental Univation® XF Pro Implant | Biotech Hunter | Biotech Hunter